|
1
|
Ura B, Scrimin F, Arrigoni G, Aloisio M,
Monasta L and Ricci G: Dysregulated chaperones associated with cell
proliferation and negative apoptosis regulation in the uterine
leiomyoma. Oncol Lett. 15:8005–8010. 2018.PubMed/NCBI
|
|
2
|
Okolo S: Incidence, aetiology and
epidemiology of uterine fibroids. Best Pract Res Clin Obstet
Gynaecol. 22:571–588. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ura B, Di Lorenzo G, Romano F, Monasta L,
Mirenda G, Scrimin F and Ricci G: Interstitial fluid in gynecologic
tumors and its possible application in the clinical practice. Int J
Mol Sci. 19:2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Moravek MB, Yin P, Ono M, Coon JS V, Dyson
MT, Navarro A, Marsh EE, Chakravarti D, Kim JJ, Wei JJ and Bulun
SE: Ovarian steroids, stem cells and uterine leiomyoma: Therapeutic
implications. Hum Reprod Update. 21:1–12. 2015. View Article : Google Scholar
|
|
5
|
Ura B, Scrimin F, Monasta L, Radillo O and
Ricci G: Association between up-regulated expression proteins and
circulating steroidal hormones in leiomyoma. Med Hypotheses.
85:5152015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ardito F, Giuliani M, Perrone D, Troiano G
and Lo Muzio L: The crucial role of protein phosphorylation in cell
signaling and its use as targeted therapy (Review). Int J Mol Med.
40:271–280. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nishi H, Shaytan A and Panchenko AR:
Physicochemical mechanisms of protein regulation by
phosphorylation. Front Genet. 5:2702014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ura B, Monasta L, Arrigoni G, Battisti I,
Licastro D, Di Lorenzo G, Romano F, Aloisio M, Peterlunger I,
Stabile G, et al: Phosphoproteins involved in the inhibition of
apoptosis and in cell survival in the leiomyoma. J Clin Med.
8:2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kovács KA, Oszter A, Göcze PM, Környei JL
and Szabó I: Comparative analysis of cyclin D1 and oestrogen
receptor (alpha and beta) levels in human leiomyoma and adjacent
myometrium. Mol Hum Reprod. 7:1085–1091. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu L, Saile K, Swartz CD, He H, Zheng X,
Kissling GE, Di X, Lucas S, Robboy SJ and Dixon D: Differential
expression of receptor tyrosine kinases (RTKs) and IGF-I pathway
activation in human uterine leiomyomas. Mol Med. 14:264–275. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chegini N, Luo X, Ding L and Ripley D: The
expression of Smads and transforming growth factor beta receptors
in leiomyoma and myometrium and the effect of gonadotropin
releasing hormone analogue therapy. Mol Cell Endocrinol. 209:9–16.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fletcher NM, Abusamaan MS, Memaj I, Saed
MG, Al-Hendy A, Diamond MP and Saed GM: Oxidative stress: A key
regulator of leiomyoma cell survival. Fertil Steril.
107:1387.e1–1394.e1. 2017. View Article : Google Scholar
|
|
13
|
Fletcher NM, Saed MG, Abu-Soud HM,
Al-Hendy A, Diamond MP and Saed GM: Uterine fibroids are
character-ized by an impaired antioxidant cellular system:
Potential role of hypoxia in the pathophysiology of uterine
fibroids. J Assist Reprod Genet. 30:969–974. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Storz P: KRas, ROS and the initiation of
pancreatic cancer. Small GTPases. 8:38–42. 2017. View Article : Google Scholar :
|
|
15
|
Storz P and Toker A: Protein kinase D
mediates a stress-induced NF-kappaB activation and survival
pathway. EMBO J. 22:109–120. 2003. View Article : Google Scholar :
|
|
16
|
Schroyer AL, Stimes NW, Abi Saab WF and
Chadee DN: MLK3 phosphorylation by ERK1/2 is required for oxidative
stress-induced invasion of colorectal cancer cells. Oncogene.
37:1031–1040. 2018. View Article : Google Scholar :
|
|
17
|
Carcoforo P, Ura B, Mischiati C,
Squerzanti M, Lanzara V, Cervellati C, Calza R, De Laureto PP,
Frare E, Portinari M, et al: Comparative proteomic analysis of
ductal breast carcinoma demonstrates an altered expression of
chaperonins and cytoskel-etal proteins. Mol Med Rep. 7:1700–1704.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ura B, Monasta L, Arrigoni G, Franchin C,
Radillo O, Peterlunger I, Ricci G and Scrimin F: A proteomic
approach for the identification of biomarkers in endometrial cancer
uterine aspirate. Oncotarget. 8:109536–109545. 2017. View Article : Google Scholar
|
|
19
|
Ura B, Scrimin F, Arrigoni G, Athanasakis
E, Aloisio M, Monasta L and Ricci G: Abnormal expression of
leiomyoma cytoskeletal proteins involved in cell migration. Oncol
Rep. 35:3094–3100. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ura B, Scrimin F, Franchin C, Arrigoni G,
Licastro D, Monasta L and Ricci G: Identification of proteins with
different abundance associated with cell migration and
proliferation in leiomyoma interstitial fluid by proteomics. Oncol
Lett. 13:3912–3920. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lemmon MA and Schlessinger J: Cell
signaling by receptor tyrosine kinases. Cell. 141:1117–1134. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Basu A, Banerjee H, Rojas H, Martinez SR,
Roy S, Jia Z, Lilly MB, De León M and Casiano CA: Differential
expression of peroxiredoxins in prostate cancer: Consistent
upregulation of PRDX3 and PRDX4. Prostate. 71:755–765. 2011.
View Article : Google Scholar :
|
|
23
|
Jiang H, Wu L, Mishra M, Chawsheen HA and
Wei Q: Expression of peroxiredoxin 1 and 4 promotes human lung
cancer malignancy. Am J Cancer Res. 4:445–460. 2014.PubMed/NCBI
|
|
24
|
Yi N, Xiao MB, Ni WK, Jiang F, Lu CH and
Ni RZ: High expression of peroxiredoxin 4 affects the survival time
of colorectal cancer patients, but is not an independent
unfavorable prognostic factor. Mol Clin Oncol. 2:767–772. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rogalla T, Ehrnsperger M, Preville X,
Kotlyarov A, Lutsch G, Ducasse C, Paul C, Wieske M, Arrigo AP,
Buchner J and Gaestel M: Regulation of Hsp27 oligomerization,
chaperone function, and protective activity against oxidative
stress/tumor necrosis factor alpha by phosphorylation. J Biol Chem.
274:18947–18956. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Garrido C, Brunet M, Didelot C, Zermati Y,
Schmitt E and Kroemer G: Heat shock proteins 27 and 70:
Anti-apoptotic proteins with tumorigenic properties. Cell Cycle.
5:2592–2601. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kamariah N, Sek MF, Eisenhaber B,
Eisenhaber F and Grüber G: Transition steps in peroxide reduction
and a molecular switch for peroxide robustness of prokaryotic
peroxiredoxins. Sci Rep. 6:376102016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kwon T, Rho JK, Lee JC, Park YH, Shin HJ,
Cho S, Kang YK, Kim BY, Yoon DY and Yu DY: An important role for
peroxiredoxin II in survival of A549 lung cancer cells resistant to
gefitinib. Exp Mol Med. 47:e1652015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Abdullah M, Schultz H, Kähler D,
Branscheid D, Dalhoff K, Zabel P, Vollmer E and Goldmann T:
Expression of the acute phase protein haptoglobin in human lung
cancer and tumor-free lung tissues. Pathol Res Pract. 205:639–647.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fedorovych IP, Tymochko MF, Fedevych IuM,
Fetsich TG and Korobov VM: Serum haptoglobin in lung cancer
patients. Ukr Biokhim Zh 1978. 67:103–105. 1995.In Ukrainian.
|
